Tech Company Financing Transactions

NuPathe Funding Round

NuPathe closed a $30 million Series B funding round on 7/24/2008. Backers included Quaker Partners, SR One Capital Management and Battelle Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Quaker Partners (Lead Investor) (Richard Kollender)

SR One Capital Management (Lead Investor) (Michael Diem)

Battelle Ventures (Tracy Warren)

Bay City Capital (Jeanne Cunicelli)

BioAdvance Ventures

Birchmere Ventures

Safeguard Scientifics (Gary Kurtzman)

Proceeds Purpose
Jane Hollingsworth, chief executive officer and co-founder of NuPathe Inc. said, "NuPathe is now in a position to optimize the development and commercialization of NP101, a unique treatment for acute migraine, as well as NP201, a novel product for Parkinson's disease."

Company Information

Company Status
Acquired or Merged
Mailing Address
227 Washington Street 200
Conshohocken, PA 19428
Email Address
NuPathe Inc. is a specialty pharmaceutical company specializing in the acquisition and development of important and innovative therapeutic products in the area of neuroscience.
NuPathe LinkedIn Company Profile
Social Media
NuPathe Company Twitter Account
Company News
NuPathe News
NuPathe on Facebook
NuPathe on YouTube

Management Team

Email & Social
Chief Executive Officer
Armando Anido
  Armando Anido LinkedIn Profile  Armando Anido Twitter Account  Armando Anido News  Armando Anido on Facebook
Chief Financial Officer
Keith Goldan
  Keith Goldan LinkedIn Profile  Keith Goldan Twitter Account  Keith Goldan News  Keith Goldan on Facebook
Chief Scientific Officer
MarK Pierce
  MarK Pierce LinkedIn Profile  MarK Pierce Twitter Account  MarK Pierce News  MarK Pierce on Facebook
Terri Sebree
  Terri Sebree LinkedIn Profile  Terri Sebree Twitter Account  Terri Sebree News  Terri Sebree on Facebook
VP - General Counsel
Michael Marino
  Michael Marino LinkedIn Profile  Michael Marino Twitter Account  Michael Marino News  Michael Marino on Facebook
VP - Operations
Ezra Felker
  Ezra Felker LinkedIn Profile  Ezra Felker Twitter Account  Ezra Felker News  Ezra Felker on Facebook



Browse more venture capital transactions:

Prev: 7/24/2008: Meetup venture capital transaction
Next: 7/25/2008: Cara Therapeutics venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary